Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Gross Margin: 2023-2025

Historic Gross Margin for Inhibrx Biosciences (INBX) over the last 3 years, with Sep 2025 value amounting to 100.00%.

  • Inhibrx Biosciences' Gross Margin was N/A to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Inhibrx Biosciences' Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Gross Margin ranged from a high of 100.00% in Q2 2023 and a low of 100.00% during Q2 2023.
  • In the last 3 years, Inhibrx Biosciences' Gross Margin had a median value of 100.00% in 2025 and averaged 100.00%.